Home

Habiliter air Antagonisme ct26 colon cancer Embrayage binaire Des sports

Reduced growth of the CT26 colon carcinoma in syngeneic MIF 2/2 mice.... |  Download Scientific Diagram
Reduced growth of the CT26 colon carcinoma in syngeneic MIF 2/2 mice.... | Download Scientific Diagram

Cancer-derived Exosomes Activate Immune Surveillance and Suppress  Peritoneal Metastasis of Murine Colonic Cancer | Anticancer Research
Cancer-derived Exosomes Activate Immune Surveillance and Suppress Peritoneal Metastasis of Murine Colonic Cancer | Anticancer Research

Establishment of the mouse colon cancer lung metastasis | Open-i
Establishment of the mouse colon cancer lung metastasis | Open-i

Molecules | Free Full-Text | In Vitro Inhibitory Potential of Different  Anthocyanin-Rich Berry Extracts in Murine CT26 Colon Cancer Cells
Molecules | Free Full-Text | In Vitro Inhibitory Potential of Different Anthocyanin-Rich Berry Extracts in Murine CT26 Colon Cancer Cells

Apoptosis of colon cancer CT-26 cells induced polysaccharide from  Cyclocarya paliurus and its phosphorylated derivative via intrinsic  mitochondrial passway - ScienceDirect
Apoptosis of colon cancer CT-26 cells induced polysaccharide from Cyclocarya paliurus and its phosphorylated derivative via intrinsic mitochondrial passway - ScienceDirect

Dual CTLA-4 and PD-L1 blockade inhibits CT26 colon cancer growth. A,... |  Download Scientific Diagram
Dual CTLA-4 and PD-L1 blockade inhibits CT26 colon cancer growth. A,... | Download Scientific Diagram

Enhancement of oxaliplatin-induced cell apoptosis and tumor suppression by  3-methyladenine in colon cancer
Enhancement of oxaliplatin-induced cell apoptosis and tumor suppression by 3-methyladenine in colon cancer

Apatinib enhanced anti-PD-1 therapy for colon cancer in mice via promoting  PD-L1 expression - ScienceDirect
Apatinib enhanced anti-PD-1 therapy for colon cancer in mice via promoting PD-L1 expression - ScienceDirect

Tumor-immune profiling of CT-26 and Colon 26 syngeneic mouse models reveals  mechanism of anti-PD-1 response | BMC Cancer | Full Text
Tumor-immune profiling of CT-26 and Colon 26 syngeneic mouse models reveals mechanism of anti-PD-1 response | BMC Cancer | Full Text

JNT | Free Full-Text | Magnetomechanical Stress-Induced Colon Cancer Cell  Growth Inhibition
JNT | Free Full-Text | Magnetomechanical Stress-Induced Colon Cancer Cell Growth Inhibition

CT26 Tumor Model | Melior Discovery
CT26 Tumor Model | Melior Discovery

The K-Ras(G12D)-inhibitory peptide KS-58 suppresses growth of murine CT26  colorectal cancer cell-derived tumors | Scientific Reports
The K-Ras(G12D)-inhibitory peptide KS-58 suppresses growth of murine CT26 colorectal cancer cell-derived tumors | Scientific Reports

sICD inducing chemo-immunotherapy in a mouse model of CT26 colon... |  Download Scientific Diagram
sICD inducing chemo-immunotherapy in a mouse model of CT26 colon... | Download Scientific Diagram

Frontiers | Low-dose immunogenic chemotherapeutics promotes immune  checkpoint blockade in microsatellite stability colon cancer
Frontiers | Low-dose immunogenic chemotherapeutics promotes immune checkpoint blockade in microsatellite stability colon cancer

CT26-Luc: An orthotopic murine model of colon cancer: implications for  immuno-oncology studies
CT26-Luc: An orthotopic murine model of colon cancer: implications for immuno-oncology studies

Histopathology of CT26 colon cancer cell line-induced tumor in mice. C... |  Download Scientific Diagram
Histopathology of CT26 colon cancer cell line-induced tumor in mice. C... | Download Scientific Diagram

Checkpoint regulator B7x is epigenetically regulated by HDAC3 and mediates  resistance to HDAC inhibitors by reprogramming the tumor immune environment  in colorectal cancer | Cell Death & Disease
Checkpoint regulator B7x is epigenetically regulated by HDAC3 and mediates resistance to HDAC inhibitors by reprogramming the tumor immune environment in colorectal cancer | Cell Death & Disease

Synergistic and low adverse effect cancer immunotherapy by immunogenic  chemotherapy and locally expressed PD-L1 trap | Nature Communications
Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap | Nature Communications

In vivo growth suppression of CT-26 mouse colorectal cancer cells by  adenovirus-expressed small hairpin RNA specifically targeting thymosin  beta-4 mRNA | Cancer Gene Therapy
In vivo growth suppression of CT-26 mouse colorectal cancer cells by adenovirus-expressed small hairpin RNA specifically targeting thymosin beta-4 mRNA | Cancer Gene Therapy

MUC1‑induced immunosuppression in colon cancer can be reversed by blocking  the PD1/PDL1 signaling pathway
MUC1‑induced immunosuppression in colon cancer can be reversed by blocking the PD1/PDL1 signaling pathway

Relative tumor volumes in mice CT26 colon cancer cell line-induced... |  Download Scientific Diagram
Relative tumor volumes in mice CT26 colon cancer cell line-induced... | Download Scientific Diagram

Tumor-immune profiling of CT-26 and Colon 26 syngeneic mouse models reveals  mechanism of anti-PD-1 response | BMC Cancer | Full Text
Tumor-immune profiling of CT-26 and Colon 26 syngeneic mouse models reveals mechanism of anti-PD-1 response | BMC Cancer | Full Text

CXCL2-CXCR2 axis mediates αV integrin-dependent peritoneal metastasis of colon  cancer cells | Clinical & Experimental Metastasis
CXCL2-CXCR2 axis mediates αV integrin-dependent peritoneal metastasis of colon cancer cells | Clinical & Experimental Metastasis

IJMS | Free Full-Text | 5-Fluorouracil Treatment of CT26 Colon Cancer Is  Compromised by Combined Therapy with IMMODIN
IJMS | Free Full-Text | 5-Fluorouracil Treatment of CT26 Colon Cancer Is Compromised by Combined Therapy with IMMODIN

Inhibition of tumor growth in CT-26 colorectal cancer-bearing mice with  alcoholic extracts of Curcuma longa and Rosmarinus officinalis -  ScienceDirect
Inhibition of tumor growth in CT-26 colorectal cancer-bearing mice with alcoholic extracts of Curcuma longa and Rosmarinus officinalis - ScienceDirect

In Vivo Antitumor Effect against Murine Cells of CT26 Colon Cancer and EL4  Lymphoma by Autologous Whole Tumor Dead Cells
In Vivo Antitumor Effect against Murine Cells of CT26 Colon Cancer and EL4 Lymphoma by Autologous Whole Tumor Dead Cells